Trinity Biotech Plc ADR (NASDAQ:TRIB) has a beta value of 1.02 and has seen 90.65 million shares traded in the recent trading session. The company, currently valued at $12.84M, closed the recent trade at $1.13 per share which meant it gained $0.37 on the day or 48.61% during that session. The TRIB stock price is -214.16% off its 52-week high price of $3.55 and 34.51% above the 52-week low of $0.74. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.12 million shares traded. The 3-month trading volume is 172.86K shares.
Trinity Biotech Plc ADR (NASDAQ:TRIB) trade information
Sporting 48.61% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the TRIB stock price touched $1.13 or saw a rise of 22.07%. Year-to-date, Trinity Biotech Plc ADR shares have moved 28.31%, while the 5-day performance has seen it change 40.30%. Over the past 30 days, the shares of Trinity Biotech Plc ADR (NASDAQ:TRIB) have changed 36.48%. Short interest in the company has seen 94129.0 shares shorted with days to cover at 0.43.
Trinity Biotech Plc ADR (TRIB) estimates and forecasts
Figures show that Trinity Biotech Plc ADR shares have outperformed across the wider relevant industry. The company’s shares have lost -60.51% over the past 6 months, with this year growth rate of 48.37%, compared to 11.70% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 9.90% over the past 5 years.
TRIB Dividends
Trinity Biotech Plc ADR is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
